Blood Glucose Device Market, Users Global Forecast 2022-2027, SMBG Components, Industry Trends, Growth, Insight, Impact of COVID-19, Company Analysis
Buy NowBlood Glucose Device Market Outlook
Self-Monitoring Blood Glucose Devices Market is expected to reach US$ 46.69 Billion in 2027. Over time, typical lab diagnostic tests have only served to assist physicians in diagnosing disease. Patients with more fluctuating glucose levels, on the other hand, need their levels monitored every day. Also, patients who use insulin need to regularly monitor their blood glucose levels. As a result, a current diabetes care approach involving blood glucose meters by patients to promptly check their glucose levels and provide an accurate assessment of capillary glucose concentration is known as self-monitoring blood glucose (SMBG). Additionally, blood glucose monitoring aids diabetic patients in making daily management decisions such as food consumption, insulin dosage, and physical activity.
Self-Monitoring Blood Glucose Devices Industry is anticipated to expand with a CAGR of 4.12% from 2021 to 2027:
The increased prevalence of diabetes is attributable to the market growth of self-monitoring blood glucose gadgets. Furthermore, lifestyle changes, food choices, increased smoking, and alcohol intake are likely to increase diabetes prevalence rates. Again, as people become more aware of home monitoring and the importance of regular diabetes treatment to lower the risk of hyperglycemia, demand for self-monitoring blood glucose monitors is increasing.
In addition, the government is launching several programs to raise public awareness about early diagnosis. The National Diabetes Education Program (NDEP) collaborated with the Centers for Disease Control and Prevention (CDC) and the NIH. The National Diabetes Education Program (NDEP) strives to lessen the prevalence of prediabetes by delivering diabetes-related education to an eclectic group of people, including hard-to-reach inhabitants, faith-based communities, ethnic minorities, community-based organizations, and healthcare providers.
COVID-19 Influence on Self-Monitoring Blood Glucose Devices Industry:
The COVID-19 epidemic has augmented the growth of the Self-Monitoring Blood Glucose Devices Market. Due to the pandemic, a few market participants reported an increase in diabetes care revenue. For example, Abbott claimed in June 2020 that their glucose monitoring device FreeStyleLibre accounted for 59.3 percent of the company's sales growth in the first quarter of 2020. With the increased risk of coronavirus transmission among diabetes patients, a new focus has been on home usage monitoring devices to help patients regulate their blood glucose levels. According to Renub Research, Self-Monitoring Blood Glucose Devices Market was US$ 36.64 Billion in 2021.
Global Self-Monitoring Blood Glucose Devices Market Segmentation:
The self-monitoring blood glucose devices industry is categorized into Type 1 Diabetes and Type 2 Diabetes perspective for Diabetes Population, Blood Glucose Devices (SMBG) Market (Test Strips, Lancet, Glucose Meter), Blood Glucose Device (SMBG) Users and Reimbursement of Blood Glucose Devices of 17 Countries (United States, United Kingdom, Germany, Spain, Italy, Netherlands, Norway, Sweden, Switzerland, Australia, Kuwait, Brazil, Russia, India, China, South Africa, and Saudi Arabia)
Competitive Landscape:
The leading worldwide self-monitoring blood glucose market players are Roche Diagnostic, Abbott Laboratories, Dexcom, Inc., Medtronic, B. Braun Melsungen AG, and DarioHealth Corp. According to our data, these firms have a global market presence and hold a significant portion of the market. At the same time, the remaining manufacturers are limited to other local or regional manufacturers. Recent mergers and acquisitions between the participants have aided the corporations in strengthening their market presence.
Renub Research latest report “Self-Monitoring Blood Glucose Devices Market, Global Forecast (Type 1 Diabetes and Type 2 Diabetes), (Diabetes Population, Blood Glucose Devices (SMBG) Market (Test Strips, Lancet, Glucose Meter), Blood Glucose Device (SMBG) Users and Reimbursement of Blood Glucose Devices), Countries (United States, United Kingdom, Germany, Spain, Italy, Netherlands, Norway, Sweden, Switzerland, Australia, Kuwait, Brazil, Russia, India, China, South Africa, and Saudi Arabia), Companies (Roche Diagnostic, Abbott Laboratories, Dexcom, Inc., Medtronic, B. Braun Melsungen AG, and DarioHealth Corp.)” provides a detailed analysis of Self-Monitoring Blood Glucose Devices Industry.
Self-Monitoring Blood Glucose Devices Market has been studied for 17 Countries:
1. United States
2. United Kingdom
3. Germany
4. Spain
5. Italy
6. Netherlands
7. Norway
8. Sweden
9. Switzerland
10. Australia
11. Kuwait
12. Brazil
13. Russia
14. India
15. China
16. South Africa
17. Saudi Arabia
Self-Monitoring Blood Glucose Devices Market for the above mentioned countries is categorized from 2 viewpoints:
1. Type 1 Diabetes
2. Type 2 Diabetes
Further, the market for Type 1 Diabetes and Type 2 Diabetes have been covered from 4 viewpoints:
1. Diabetes Population
2. Blood Glucose Devices (SMBG) Market
a) Test Strips
b) Lancet,
c) Glucose Meter
3. Blood Glucose Device (SMBG) Users
4. Reimbursement of Blood Glucose Devices
Report Details:
| Report Features | Details |
| Base Year | 2021 |
| Historical Period | 2017 - 2021 |
| Forecast Period | 2022 - 2027 |
| Market | US$ Billion |
| Segment Covered | Type 1 Diabetes Type 2 Diabetes |
| Region Covered | 17 Countries |
| Companies Covered | Roche Diagnostic, Abbott Laboratories, Dexcom, Inc., Medtronic, B. Braun Melsungen AG, and DarioHealth Corp. |
| Customization Scope | 20% Free Customization |
| Post-Sale Analyst Support | 1 Year (52 Weeks) |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on request) |
Frequently Asked Questions:
1. What is the Diabetes population of Western Countries?
2. Which are the top companies in self-monitoring blood glucose devices market?
3. What are the key trends in the blood glucose monitoring devices market?
4. What is the CAGR of glucose test strips market?
5. What has been the COVID-19 impact on self-monitoring blood glucose devices industry?
1. Introduction
2. Research & Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Global Blood Glucose (SMBG) Market and Users
5.1 Blood Glucose Device Market (Type1 + Type 2) Diabetes
5.1.1 Type 1 Diabetes
5.1.2 Type 2 Diabetes
5.2 Test Strips Market and Forecast
5.2.1 Type 1 Diabetes
5.2.2 Type 2 Diabetes
5.3 Lancet Market and Forecast
5.3.1 Type 1 Diabetes
5.3.2 Type 2 Diabetes
5.4 Meter Market and Forecast
5.4.1 Type 1 Diabetes
5.4.2 Type 2 Diabetes
5.5 Global Diabetes Population (Type1 + Type 2)
5.5.1 Type 1 Diabetes Population
5.5.2 Type 2 Diabetes Population
5.6 Blood Glucose (SMBG) Device Users (Type1 + Type 2)
5.6.1 Type 1 Diabetes Blood Glucose (SMBG) Device Users
5.6.2 Type 2 Diabetes Blood Glucose (SMBG) Device Users
6. Share Analysis – Blood Glucose Device Market, Diabetes Population, SMBG User
6.1 SMBG Market Share
6.1.1 Total SMBG Market Share
6.1.1.1 Type 1
6.1.1.2 Type 2
6.1.2 Test Strips
6.1.2.1 Type 1
6.1.2.2 Type 2
6.1.3 Lancet
6.1.3.1 Type 1
6.1.3.2 Type 2
6.1.4 Blood Glucose Meter
6.1.4.1 Type 1
6.1.4.2 Type 2
6.1.5 Diabetes Population Share
6.1.5.1 Type 1 Diabetes
6.1.5.2 Type 2 Diabetes
6.1.6 Blood Glucose Device User Share & Forecast
6.1.6.1 Type 1 Diabetes
6.1.6.2 Type 2 Diabetes
7. United States
7.1 United States Diabetes Population
7.1.1 Type 1 Diabetes
7.1.2 Type 2 Diabetes
7.2 Blood Glucose Device (SMBG) Market
7.2.1 Test Strips (Diabetes) Market
7.2.1.1 Type 1
7.2.1.2 Type 2
7.2.2 Lancet (Diabetes) Market
7.2.2.1 Type 1
7.2.2.2 Type 2
7.2.3 Glucose Meter (Diabetes) Market
7.2.3.1 Type 1
7.2.3.2 Type 2
7.3 Blood Glucose (SMBG) (Diabetes) Users
7.3.1 Type 1
7.3.2 Type 2
7.4 Reimbursement of Blood Glucose Devices in United States
8. United Kingdom
8.1 United Kingdom Diabetes Population
8.1.1 Type 1 Diabetes
8.1.2 Type 2 Diabetes
8.2 Blood Glucose Device (SMBG) Market
8.2.1 Test Strips (Diabetes) Market
8.2.1.1 Type 1
8.2.1.2 Type 2
8.2.2 Lancet (Diabetes) Market
8.2.2.1 Type 1
8.2.2.2 Type 2
8.2.3 Glucose Meter (Diabetes) Market
8.2.3.1 Type 1
8.2.3.2 Type 2
8.3 Blood Glucose (SMBG) (Diabetes) Users
8.3.1 Type 1
8.3.2 Type 2
8.4 Reimbursement of Blood Glucose Devices in United Kingdom
9. Germany
9.1 Germany Diabetes Population
9.1.1 Type 1 Diabetes
9.1.2 Type 2 Diabetes
9.2 Blood Glucose Device (SMBG) Market
9.2.1 Test Strips (Diabetes) Market
9.2.1.1 Type 1
9.2.1.2 Type 2
9.2.2 Lancet (Diabetes) Market
9.2.2.1 Type 1
9.2.2.2 Type 2
9.2.3 Glucose Meter (Diabetes) Market
9.2.3.1 Type 1
9.2.3.2 Type 2
9.3 Blood Glucose (SMBG) (Diabetes) Users
9.3.1 Type 1
9.3.2 Type 2
9.4 Reimbursement of Blood Glucose Devices in Germany
10. Spain
10.1 Spain Diabetes Population
10.1.1 Type 1 Diabetes
10.1.2 Type 2 Diabetes
10.2 Blood Glucose Device (SMBG) Market
10.2.1 Test Strips (Diabetes) Market
10.2.1.1 Type 1
10.2.1.2 Type 2
10.2.2 Lancet (Diabetes) Market
10.2.2.1 Type 1
10.2.2.2 Type 2
10.2.3 Glucose Meter (Diabetes) Market
10.2.3.1 Type 1
10.2.3.2 Type 2
10.3 Blood Glucose (SMBG) (Diabetes) Users
10.3.1 Type 1
10.3.2 Type 2
10.4 Reimbursement of Blood Glucose Devices in Spain
11. Italy
11.1 Italy Diabetes Population
11.1.1 Type 1 Diabetes
11.1.2 Type 2 Diabetes
11.2 Blood Glucose Device (SMBG) Market
11.2.1 Test Strips (Diabetes) Market
11.2.1.1 Type 1
11.2.1.2 Type 2
11.2.2 Lancet (Diabetes) Market
11.2.2.1 Type 1
11.2.2.2 Type 2
11.2.3 Glucose Meter (Diabetes) Market
11.2.3.1 Type 1
11.2.3.2 Type 2
11.3 Blood Glucose (SMBG) (Diabetes) Users
11.3.1 Type 1
11.3.2 Type 2
11.4 Reimbursement of Blood Glucose Devices in Italy
12. Netherlands
12.1 Netherlands Diabetes Population
12.1.1 Type 1 Diabetes
12.1.2 Type 2 Diabetes
12.2 Blood Glucose Device (SMBG) Market
12.2.1 Test Strips (Diabetes) Market
12.2.1.1 Type 1
12.2.1.2 Type 2
12.2.2 Lancet (Diabetes) Market
12.2.2.1 Type 1
12.2.2.2 Type 2
12.2.3 Glucose Meter (Diabetes) Market
12.2.3.1 Type 1
12.2.3.2 Type 2
12.3 Blood Glucose (SMBG) (Diabetes) Users
12.3.1 Type 1
12.3.2 Type 2
12.4 Reimbursement of Blood Glucose Devices in Netherlands
13. Norway
13.1 Norway Diabetes Population
13.1.1 Type 1 Diabetes
13.1.2 Type 2 Diabetes
13.2 Blood Glucose Device (SMBG) Market
13.2.1 Test Strips (Diabetes) Market
13.2.1.1 Type 1
13.2.1.2 Type 2
13.2.2 Lancet (Diabetes) Market
13.2.2.1 Type 1
13.2.2.2 Type 2
13.2.3 Glucose Meter (Diabetes) Market
13.2.3.1 Type 1
13.2.3.2 Type 2
13.3 Blood Glucose (SMBG) (Diabetes) Users
13.3.1 Type 1
13.3.2 Type 2
13.4 Reimbursement of Blood Glucose Devices in Norway
14. Sweden
14.1 Sweden Diabetes Population
14.1.1 Type 1 Diabetes
14.1.2 Type 2 Diabetes
14.2 Blood Glucose Device (SMBG) Market
14.2.1 Test Strips (Diabetes) Market
14.2.1.1 Type 1
14.2.1.2 Type 2
14.2.2 Lancet (Diabetes) Market
14.2.2.1 Type 1
14.2.2.2 Type 2
14.2.3 Glucose Meter (Diabetes) Market
14.2.3.1 Type 1
14.2.3.2 Type 2
14.3 Blood Glucose (SMBG) (Diabetes) Users
14.3.1 Type 1
14.3.2 Type 2
14.4 Reimbursement of Blood Glucose Devices in Sweden
15. Switzerland
15.1 Switzerland Diabetes Population
15.1.1 Type 1 Diabetes
15.1.2 Type 2 Diabetes
15.2 Blood Glucose Device (SMBG) Market
15.2.1 Test Strips (Diabetes) Market
15.2.1.1 Type 1
15.2.1.2 Type 2
15.2.2 Lancet (Diabetes) Market
15.2.2.1 Type 1
15.2.2.2 Type 2
15.2.3 Glucose Meter (Diabetes) Market
15.2.3.1 Type 1
15.2.3.2 Type 2
15.3 Blood Glucose (SMBG) (Diabetes) Users
15.3.1 Type 1
15.3.2 Type 2
15.4 Reimbursement of Blood Glucose Devices in Switzerland
16. Australia
16.1 Australia Diabetes Population
16.1.1 Type 1 Diabetes
16.1.2 Type 2 Diabetes
16.2 Blood Glucose Device (SMBG) Market
16.2.1 Test Strips (Diabetes) Market
16.2.1.1 Type 1
16.2.1.2 Type 2
16.2.2 Lancet (Diabetes) Market
16.2.2.1 Type 1
16.2.2.2 Type 2
16.2.3 Glucose Meter (Diabetes) Market
16.2.3.1 Type 1
16.2.3.2 Type 2
16.3 Blood Glucose (SMBG) (Diabetes) Users
16.3.1 Type 1
16.3.2 Type 2
16.4 Reimbursement of Blood Glucose Devices in Australia
17. Kuwait
17.1 Kuwait Diabetes Population
17.1.1 Type 1 Diabetes
17.1.2 Type 2 Diabetes
17.2 Blood Glucose Device (SMBG) Market
17.2.1 Test Strips (Diabetes) Market
17.2.1.1 Type 1
17.2.1.2 Type 2
17.2.2 Lancet (Diabetes) Market
17.2.2.1 Type 1
17.2.2.2 Type 2
17.2.3 Glucose Meter (Diabetes) Market
17.2.3.1 Type 1
17.2.3.2 Type 2
17.3 Blood Glucose (SMBG) (Diabetes) Users
17.3.1 Type 1
17.3.2 Type 2
17.4 Reimbursement of Blood Glucose Devices in Kuwait
18. Brazil
18.1 Brazil Diabetes Population
18.1.1 Type 1 Diabetes
18.1.2 Type 2 Diabetes
18.2 Blood Glucose Device (SMBG) Market
18.2.1 Test Strips (Diabetes) Market
18.2.1.1 Type 1
18.2.1.2 Type 2
18.2.2 Lancet (Diabetes) Market
18.2.2.1 Type 1
18.2.2.2 Type 2
18.2.3 Glucose Meter (Diabetes) Market
18.2.3.1 Type 1
18.2.3.2 Type 2
18.3 Blood Glucose (SMBG) (Diabetes) Users
18.3.1 Type 1
18.3.2 Type 2
18.4 Reimbursement of Blood Glucose Devices in Brazil
19. Russia
19.1 Russia Diabetes Population
19.1.1 Type 1 Diabetes
19.1.2 Type 2 Diabetes
19.2 Blood Glucose Device (SMBG) Market
19.2.1 Test Strips (Diabetes) Market
19.2.1.1 Type 1
19.2.1.2 Type 2
19.2.2 Lancet (Diabetes) Market
19.2.2.1 Type 1
19.2.2.2 Type 2
19.2.3 Glucose Meter (Diabetes) Market
19.2.3.1 Type 1
19.2.3.2 Type 2
19.3 Blood Glucose (SMBG) (Diabetes) Users
19.3.1 Type 1
19.3.2 Type 2
19.4 Reimbursement of Blood Glucose Devices in Russia
20. India
20.1 India Diabetes Population
20.1.1 Type 1 Diabetes
20.1.2 Type 2 Diabetes
20.2 Blood Glucose Device (SMBG) Market
20.2.1 Test Strips (Diabetes) Market
20.2.1.1 Type 1
20.2.1.2 Type 2
20.2.2 Lancet (Diabetes) Market
20.2.2.1 Type 1
20.2.2.2 Type 2
20.2.3 Glucose Meter (Diabetes) Market
20.2.3.1 Type 1
20.2.3.2 Type 2
20.3 Blood Glucose (SMBG) (Diabetes) Users
20.3.1 Type 1
20.3.2 Type 2
20.4 Reimbursement of Blood Glucose Devices in India
21. China
21.1 China Diabetes Population
21.1.1 Type 1 Diabetes
21.1.2 Type 2 Diabetes
21.2 Blood Glucose Device (SMBG) Market
21.2.1 Test Strips (Diabetes) Market
21.2.1.1 Type 1
21.2.1.2 Type 2
21.2.2 Lancet (Diabetes) Market
21.2.2.1 Type 1
21.2.2.2 Type 2
21.2.3 Glucose Meter (Diabetes) Market
21.2.3.1 Type 1
21.2.3.2 Type 2
21.3 Blood Glucose (SMBG) (Diabetes) Users
21.3.1 Type 1
21.3.2 Type 2
21.4 Reimbursement of Blood Glucose Devices in China
22. South Africa
22.1 South Africa Diabetes Population
22.1.1 Type 1 Diabetes
22.1.2 Type 2 Diabetes
22.2 Blood Glucose Device (SMBG) Market
22.2.1 Test Strips (Diabetes) Market
22.2.1.1 Type 1
22.2.1.2 Type 2
22.2.2 Lancet (Diabetes) Market
22.2.2.1 Type 1
22.2.2.2 Type 2
22.2.3 Glucose Meter (Diabetes) Market
22.2.3.1 Type 1
22.2.3.2 Type 2
22.3 Blood Glucose (SMBG) (Diabetes) Users
22.3.1 Type 1
22.3.2 Type 2
22.4 Reimbursement of Blood Glucose Devices in South Africa
23. Saudi Arabia
23.1 Saudi Arabia Diabetes Population
23.1.1 Type 1 Diabetes
23.1.2 Type 2 Diabetes
23.2 Blood Glucose Device (SMBG) Market
23.2.1 Test Strips (Diabetes) Market
23.2.1.1 Type 1
23.2.1.2 Type 2
23.2.2 Lancet (Diabetes) Market
23.2.2.1 Type 1
23.2.2.2 Type 2
23.2.3 Glucose Meter (Diabetes) Market
23.2.3.1 Type 1
23.2.3.2 Type 2
23.3 Blood Glucose (SMBG) (Diabetes) Users
23.3.1 Type 1
23.3.2 Type 2
23.4 Reimbursement of Blood Glucose Devices in Saudi Arabia
24. Company Analysis
24.1 Roche Diagnostic
24.1.1 Overview
24.1.2 Recent Developments
24.1.3 Revenue
24.2 Abbott Laboratories
24.2.1 Overview
24.2.2 Recent Developments
24.2.3 Revenue
24.3 Dexcom, Inc.
24.3.1 Overview
24.3.2 Recent Developments
24.3.3 Revenue
24.4 Medtronic
24.4.1 Overview
24.4.2 Recent Developments
24.4.3 Revenue
24.5 B. Braun Melsungen AG
24.5.1 Overview
24.5.2 Recent Developments
24.5.3 Revenue
24.6 DarioHealth Corp
24.6.1 Overview
24.6.2 Recent Developments
24.6.3 Revenue
List of Figures:
Figure-01: Global – Blood Glucose (SMBG) Device Market (Million US$), 2017 – 2021
Figure-02: Global – Forecast for Blood Glucose (SMBG) Device Market (Million US$), 2022 – 2027
Figure-03: Global – Blood Glucose Device Type 1 Market (Million US$), 2017 – 2021
Figure-04: Global – Forecast for Blood Glucose Device Type 1 Market (Million US$), 2022 – 2027
Figure-05: Global – Blood Glucose Device Type 2 Market (Million US$), 2017 – 2021
Figure-06: Global – Forecast for Blood Glucose Device Type 2 Market (Million US$), 2022 – 2027
Figure-07: Global – Test Strips Type 1 Market (Million US$), 2017 – 2021
Figure-08: Global – Forecast for Test Strips Type 1 Market (Million US$), 2022 – 2027
Figure-09: Global – Test Strips Type 2 Market (Million US$), 2017 – 2021
Figure-10: Global – Forecast for Test Strips Type 2 Market (Million US$), 2022 – 2027
Figure-11: Global – Lancet Type 1 Market (Million US$), 2017 – 2021
Figure-12: Global – Forecast for Lancet Type 1 Market (Million US$), 2022 – 2027
Figure-13: Global – Lancet Type 2 Market (Million US$), 2017 – 2021
Figure-14: Global – Forecast for Lancet Type 2 Market (Million US$), 2022 – 2027
Figure-15: Global – Glucometer Type 1 Market (Million US$), 2017 – 2021
Figure-16: Global – Forecast for Glucometer Type 1 Market (Million US$), 2022 – 2027
Figure-17: Global – Glucometer Type 2 Market (Million US$), 2017 – 2021
Figure-18: Global – Forecast for Glucometer Type 2 Market (Million US$), 2022 – 2027
Figure-19: Global – Diabetes Type 1 Population Volume (Thousand), 2017 – 2021
Figure-20: Global – Forecast for Diabetes Type 1 Population Volume (Thousand), 2022 – 2027
Figure-21: Global – Diabetes Type 2 Population Volume (Thousand), 2017 – 2021
Figure-22: Global – Forecast for Diabetes Type 2 Population Volume (Thousand), 2022 – 2027
Figure-23: Global – Blood Glucose Device Type 1 Users Volume (Thousand), 2017 – 2021
Figure-24: Global – Forecast for Blood Glucose Device Type 1 Users Volume (Thousand), 2022 – 2027
Figure-25: Global – Blood Glucose Device Type 2 Users Volume (Thousand), 2017 – 2021
Figure-26: Global – Forecast for Blood Glucose Device Type 2 Users Volume (Thousand), 2022 – 2027
Figure-27: United States – Diabetes Type 1 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-28: United States – Forecast for Diabetes Type 1 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-29: United States – Diabetes Type 2 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-30: United States – Forecast for Diabetes Type 2 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-31: United States – Test Strips (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-32: United States – Forecast for Test Strips (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-33: United States – Test Strips (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-34: United States – Forecast for Test Strips (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-35: United States – Lancet (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-36: United States – Forecast for Lancet (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-37: United States – Lancet (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-38: United States – Forecast for Lancet (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-39: United States – Glucose Meter (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-40: United States – Forecast for Glucose Meter (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-41: United States – Glucose Meter (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-42: United States – Forecast for Glucose Meter (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-43: United States – Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2017 – 2021
Figure-44: United States – Forecast for Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2022 – 2027
Figure-45: United States – Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2017 – 2021
Figure-46: United States – Forecast for Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2022 – 2027
Figure-47: United Kingdom – Diabetes Type 1 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-48: United Kingdom – Forecast for Diabetes Type 1 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-49: United Kingdom – Diabetes Type 2 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-50: United Kingdom – Forecast for Diabetes Type 2 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-51: United Kingdom – Test Strips (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-52: United Kingdom – Forecast for Test Strips (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-53: United Kingdom – Test Strips (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-54: United Kingdom – Forecast for Test Strips (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-55: United Kingdom – Lancet (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-56: United Kingdom – Forecast for Lancet (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-57: United Kingdom – Lancet (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-58: United Kingdom – Forecast for Lancet (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-59: United Kingdom – Glucose Meter (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-60: United Kingdom – Forecast for Glucose Meter (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-61: United Kingdom – Glucose Meter (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-62: United Kingdom – Forecast for Glucose Meter (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-63: United Kingdom – Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2017 – 2021
Figure-64: United Kingdom – Forecast for Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2022 – 2027
Figure-65: United Kingdom – Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2017 – 2021
Figure-66: United Kingdom – Forecast for Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2022 – 2027
Figure-67: Germany – Diabetes Type 1 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-68: Germany – Forecast for Diabetes Type 1 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-69: Germany – Diabetes Type 2 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-70: Germany – Forecast for Diabetes Type 2 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-71: Germany – Test Strips (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-72: Germany – Forecast for Test Strips (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-73: Germany – Test Strips (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-74: Germany – Forecast for Test Strips (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-75: Germany – Lancet (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-76: Germany – Forecast for Lancet (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-77: Germany – Lancet (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-78: Germany – Forecast for Lancet (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-79: Germany – Glucose Meter (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-80: Germany – Forecast for Glucose Meter (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-81: Germany – Glucose Meter (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-82: Germany – Forecast for Glucose Meter (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-83: Germany – Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2017 – 2021
Figure-84: Germany – Forecast for Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2022 – 2027
Figure-85: Germany – Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2017 – 2021
Figure-86: Germany – Forecast for Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2022 – 2027
Figure-87: Spain – Diabetes Type 1 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-88: Spain – Forecast for Diabetes Type 1 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-89: Spain – Diabetes Type 2 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-90: Spain – Forecast for Diabetes Type 2 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-91: Spain – Test Strips (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-92: Spain – Forecast for Test Strips (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-93: Spain – Test Strips (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-94: Spain – Forecast for Test Strips (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-95: Spain – Lancet (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-96: Spain – Forecast for Lancet (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-97: Spain – Lancet (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-98: Spain – Forecast for Lancet (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-99: Spain – Glucose Meter (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-100: Spain – Forecast for Glucose Meter (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-101: Spain – Glucose Meter (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-102: Spain – Forecast for Glucose Meter (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-103: Spain – Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2017 – 2021
Figure-104: Spain – Forecast for Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2022 – 2027
Figure-105: Spain – Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2017 – 2021
Figure-106: Spain – Forecast for Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2022 – 2027
Figure-107: Italy – Diabetes Type 1 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-108: Italy – Forecast for Diabetes Type 1 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-109: Italy – Diabetes Type 2 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-110: Italy – Forecast for Diabetes Type 2 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-111: Italy – Test Strips (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-112: Italy – Forecast for Test Strips (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-113: Italy – Test Strips (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-114: Italy – Forecast for Test Strips (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-115: Italy – Lancet (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-116: Italy – Forecast for Lancet (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-117: Italy – Lancet (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-118: Italy – Forecast for Lancet (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-119: Italy – Glucose Meter (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-120: Italy – Forecast for Glucose Meter (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-121: Italy – Glucose Meter (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-122: Italy – Forecast for Glucose Meter (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-123: Italy – Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2017 – 2021
Figure-124: Italy – Forecast for Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2022 – 2027
Figure-125: Italy – Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2017 – 2021
Figure-126: Italy – Forecast for Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2022 – 2027
Figure-127: Netherlands – Diabetes Type 1 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-128: Netherlands – Forecast for Diabetes Type 1 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-129: Netherlands – Diabetes Type 2 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-130: Netherlands – Forecast for Diabetes Type 2 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-131: Netherlands – Test Strips (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-132: Netherlands – Forecast for Test Strips (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-133: Netherlands – Test Strips (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-134: Netherlands – Forecast for Test Strips (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-135: Netherlands – Lancet (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-136: Netherlands – Forecast for Lancet (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-137: Netherlands – Lancet (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-138: Netherlands – Forecast for Lancet (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-139: Netherlands – Glucose Meter (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-140: Netherlands – Forecast for Glucose Meter (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-141: Netherlands – Glucose Meter (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-142: Netherlands – Forecast for Glucose Meter (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-143: Netherlands – Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2017 – 2021
Figure-144: Netherlands – Forecast for Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2022 – 2027
Figure-145: Netherlands – Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2017 – 2021
Figure-146: Netherlands – Forecast for Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2022 – 2027
Figure-147: Norway – Diabetes Type 1 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-148: Norway – Forecast for Diabetes Type 1 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-149: Norway – Diabetes Type 2 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-150: Norway – Forecast for Diabetes Type 2 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-151: Norway – Test Strips (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-152: Norway – Forecast for Test Strips (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-153: Norway – Test Strips (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-154: Norway – Forecast for Test Strips (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-155: Norway – Lancet (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-156: Norway – Forecast for Lancet (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-157: Norway – Lancet (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-158: Norway – Forecast for Lancet (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-159: Norway – Glucose Meter (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-160: Norway – Forecast for Glucose Meter (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-161: Norway – Glucose Meter (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-162: Norway – Forecast for Glucose Meter (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-163: Norway – Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2017 – 2021
Figure-164: Norway – Forecast for Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2022 – 2027
Figure-165: Norway – Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2017 – 2021
Figure-166: Norway – Forecast for Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2022 – 2027
Figure-167: Sweden – Diabetes Type 1 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-168: Sweden – Forecast for Diabetes Type 1 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-169: Sweden – Diabetes Type 2 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-170: Sweden – Forecast for Diabetes Type 2 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-171: Sweden – Test Strips (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-172: Sweden – Forecast for Test Strips (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-173: Sweden – Test Strips (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-174: Sweden – Forecast for Test Strips (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-175: Sweden – Lancet (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-176: Sweden – Forecast for Lancet (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-177: Sweden – Lancet (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-178: Sweden – Forecast for Lancet (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-179: Sweden – Glucose Meter (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-180: Sweden – Forecast for Glucose Meter (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-181: Sweden – Glucose Meter (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-182: Sweden – Forecast for Glucose Meter (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-183: Sweden – Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2017 – 2021
Figure-184: Sweden – Forecast for Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2022 – 2027
Figure-185: Sweden – Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2017 – 2021
Figure-186: Sweden – Forecast for Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2022 – 2027
Figure-187: Switzerland – Diabetes Type 1 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-188: Switzerland – Forecast for Diabetes Type 1 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-189: Switzerland – Diabetes Type 2 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-190: Switzerland – Forecast for Diabetes Type 2 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-191: Switzerland – Test Strips (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-192: Switzerland – Forecast for Test Strips (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-193: Switzerland – Test Strips (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-194: Switzerland – Forecast for Test Strips (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-195: Switzerland – Lancet (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-196: Switzerland – Forecast for Lancet (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-197: Switzerland – Lancet (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-198: Switzerland – Forecast for Lancet (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-199: Switzerland – Glucose Meter (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-200: Switzerland – Forecast for Glucose Meter (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-201: Switzerland – Glucose Meter (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-202: Switzerland – Forecast for Glucose Meter (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-203: Switzerland – Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2017 – 2021
Figure-204: Switzerland – Forecast for Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2022 – 2027
Figure-205: Switzerland – Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2017 – 2021
Figure-206: Switzerland – Forecast for Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2022 – 2027
Figure-207: Australia – Diabetes Type 1 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-208: Australia – Forecast for Diabetes Type 1 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-209: Australia – Diabetes Type 2 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-210: Australia – Forecast for Diabetes Type 2 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-211: Australia – Test Strips (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-212: Australia – Forecast for Test Strips (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-213: Australia – Test Strips (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-214: Australia – Forecast for Test Strips (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-215: Australia – Lancet (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-216: Australia – Forecast for Lancet (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-217: Australia – Lancet (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-218: Australia – Forecast for Lancet (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-219: Australia – Glucose Meter (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-220: Australia – Forecast for Glucose Meter (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-221: Australia – Glucose Meter (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-222: Australia – Forecast for Glucose Meter (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-223: Australia – Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2017 – 2021
Figure-224: Australia – Forecast for Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2022 – 2027
Figure-225: Australia – Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2017 – 2021
Figure-226: Australia – Forecast for Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2022 – 2027
Figure-227: Kuwait – Diabetes Type 1 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-228: Kuwait – Forecast for Diabetes Type 1 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-229: Kuwait – Diabetes Type 2 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-230: Kuwait – Forecast for Diabetes Type 2 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-231: Kuwait – Test Strips (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-232: Kuwait – Forecast for Test Strips (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-233: Kuwait – Test Strips (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-234: Kuwait – Forecast for Test Strips (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-235: Kuwait – Lancet (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-236: Kuwait – Forecast for Lancet (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-237: Kuwait – Lancet (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-238: Kuwait – Forecast for Lancet (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-239: Kuwait – Glucose Meter (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-240: Kuwait – Forecast for Glucose Meter (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-241: Kuwait – Glucose Meter (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-242: Kuwait – Forecast for Glucose Meter (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-243: Kuwait – Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2017 – 2021
Figure-244: Kuwait – Forecast for Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2022 – 2027
Figure-245: Kuwait – Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2017 – 2021
Figure-246: Kuwait – Forecast for Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2022 – 2027
Figure-247: Brazil – Diabetes Type 1 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-248: Brazil – Forecast for Diabetes Type 1 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-249: Brazil – Diabetes Type 2 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-250: Brazil – Forecast for Diabetes Type 2 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-251: Brazil – Test Strips (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-252: Brazil – Forecast for Test Strips (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-253: Brazil – Test Strips (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-254: Brazil – Forecast for Test Strips (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-255: Brazil – Lancet (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-256: Brazil – Forecast for Lancet (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-257: Brazil – Lancet (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-258: Brazil – Forecast for Lancet (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-259: Brazil – Glucose Meter (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-260: Brazil – Forecast for Glucose Meter (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-261: Brazil – Glucose Meter (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-262: Brazil – Forecast for Glucose Meter (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-263: Brazil – Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2017 – 2021
Figure-264: Brazil – Forecast for Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2022 – 2027
Figure-265: Brazil – Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2017 – 2021
Figure-266: Brazil – Forecast for Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2022 – 2027
Figure-267: Russia – Diabetes Type 1 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-268: Russia – Forecast for Diabetes Type 1 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-269: Russia – Diabetes Type 2 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-270: Russia – Forecast for Diabetes Type 2 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-271: Russia – Test Strips (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-272: Russia – Forecast for Test Strips (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-273: Russia – Test Strips (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-274: Russia – Forecast for Test Strips (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-275: Russia – Lancet (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-276: Russia – Forecast for Lancet (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-277: Russia – Lancet (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-278: Russia – Forecast for Lancet (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-279: Russia – Glucose Meter (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-280: Russia – Forecast for Glucose Meter (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-281: Russia – Glucose Meter (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-282: Russia – Forecast for Glucose Meter (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-283: Russia – Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2017 – 2021
Figure-284: Russia – Forecast for Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2022 – 2027
Figure-285: Russia – Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2017 – 2021
Figure-286: Russia – Forecast for Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2022 – 2027
Figure-287: India – Diabetes Type 1 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-288: India – Forecast for Diabetes Type 1 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-289: India – Diabetes Type 2 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-290: India – Forecast for Diabetes Type 2 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-291: India – Test Strips (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-292: India – Forecast for Test Strips (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-293: India – Test Strips (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-294: India – Forecast for Test Strips (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-295: India – Lancet (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-296: India – Forecast for Lancet (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-297: India – Lancet (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-298: India – Forecast for Lancet (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-299: India – Glucose Meter (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-300: India – Forecast for Glucose Meter (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-301: India – Glucose Meter (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-302: India – Forecast for Glucose Meter (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-303: India – Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2017 – 2021
Figure-304: India – Forecast for Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2022 – 2027
Figure-305: India – Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2017 – 2021
Figure-306: India – Forecast for Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2022 – 2027
Figure-307: China – Diabetes Type 1 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-308: China – Forecast for Diabetes Type 1 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-309: China – Diabetes Type 2 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-310: China – Forecast for Diabetes Type 2 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-311: China – Test Strips (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-312: China – Forecast for Test Strips (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-313: China – Test Strips (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-314: China – Forecast for Test Strips (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-315: China – Lancet (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-316: China – Forecast for Lancet (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-317: China – Lancet (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-318: China – Forecast for Lancet (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-319: China – Glucose Meter (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-320: China – Forecast for Glucose Meter (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-321: China – Glucose Meter (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-322: China – Forecast for Glucose Meter (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-323: China – Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2017 – 2021
Figure-324: China – Forecast for Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2022 – 2027
Figure-325: China – Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2017 – 2021
Figure-326: China – Forecast for Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2022 – 2027
Figure-327: South Africa – Diabetes Type 1 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-328: South Africa – Forecast for Diabetes Type 1 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-329: South Africa – Diabetes Type 2 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-330: South Africa – Forecast for Diabetes Type 2 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-331: South Africa – Test Strips (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-332: South Africa – Forecast for Test Strips (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-333: South Africa – Test Strips (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-334: South Africa – Forecast for Test Strips (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-335: South Africa – Lancet (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-336: South Africa – Forecast for Lancet (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-337: South Africa – Lancet (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-338: South Africa – Forecast for Lancet (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-339: South Africa – Glucose Meter (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-340: South Africa – Forecast for Glucose Meter (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-341: South Africa – Glucose Meter (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-342: South Africa – Forecast for Glucose Meter (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-343: South Africa – Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2017 – 2021
Figure-344: South Africa – Forecast for Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2022 – 2027
Figure-345: South Africa – Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2017 – 2021
Figure-346: South Africa – Forecast for Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2022 – 2027
Figure-347: Saudi Arabia – Diabetes Type 1 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-348: Saudi Arabia – Forecast for Diabetes Type 1 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-349: Saudi Arabia – Diabetes Type 2 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-350: Saudi Arabia – Forecast for Diabetes Type 2 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-351: Saudi Arabia – Test Strips (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-352: Saudi Arabia – Forecast for Test Strips (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-353: Saudi Arabia – Test Strips (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-354: Saudi Arabia – Forecast for Test Strips (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-355: Saudi Arabia – Lancet (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-356: Saudi Arabia – Forecast for Lancet (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-357: Saudi Arabia – Lancet (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-358: Saudi Arabia – Forecast for Lancet (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-359: Saudi Arabia – Glucose Meter (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-360: Saudi Arabia – Forecast for Glucose Meter (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-361: Saudi Arabia – Glucose Meter (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-362: Saudi Arabia – Forecast for Glucose Meter (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-363: Saudi Arabia – Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2017 – 2021
Figure-364: Saudi Arabia – Forecast for Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2022 – 2027
Figure-365: Saudi Arabia – Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2017 – 2021
Figure-366: Saudi Arabia – Forecast for Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2022 – 2027
Figure-367: Roche Diagnostic – Global Revenue (Million US$), 2017 – 2021
Figure-368: Roche Diagnostic – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-369: Abbott Laboratories – Global Revenue (Million US$), 2017 – 2021
Figure-370: Abbott Laboratories – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-371: Dexcom, Inc. – Global Revenue (Million US$), 2017 – 2021
Figure-372: Dexcom, Inc. – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-373: Medtronic – Global Revenue (Million US$), 2017 – 2021
Figure-374: Medtronic – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-375: B. Braun Melsungen AG – Global Revenue (Million US$), 2017 – 2021
Figure-376: B. Braun Melsungen AG – Forecast for Global Revenue (Million US$), 2022 – 2027
Figure-377: DarioHealth Corp – Global Revenue (Million US$), 2017 – 2021
Figure-378: DarioHealth Corp – Forecast for Global Revenue (Million US$), 2022 – 2027
List of Tables:
Table-01: Global – SMBG Market Share (Percent), 2017 – 2021
Table-02: Global – Forecast for SMBG Market Share (Percent), 2022 – 2027
Table-03: Global – SMBG Type 1 Market Share (Percent), 2017 – 2021
Table-04: Global – Forecast for SMBG Type 1 Market Share (Percent), 2022 – 2027
Table-05: Global – SMBG Type 2 Market Share (Percent), 2017 – 2021
Table-06: Global – Forecast for SMBG Type 2 Market Share (Percent), 2022 – 2027
Table-07: Global – Test Strips Type 1 Market Share (Percent), 2017 – 2021
Table-08: Global – Forecast for Test Strips Type 1 Market Share (Percent), 2022 – 2027
Table-09: Global – Test Strips Type 2 Market Share (Percent), 2017 – 2021
Table-10: Global – Forecast for Test Strips Type 2 Market Share (Percent), 2022 – 2027
Table-11: Global – Lancet Type 1 Market Share (Percent), 2017 – 2021
Table-12: Global – Forecast for Lancet Type 1 Market Share (Percent), 2022 – 2027
Table-13: Global – Lancet Type 2 Market Share (Percent), 2017 – 2021
Table-14: Global – Forecast for Lancet Type 2 Market Share (Percent), 2022 – 2027
Table-15: Global – Glucose Meter Type 1 Market Share (Percent), 2017 – 2021
Table-16: Global – Forecast for Glucose Meter Type 1 Market Share (Percent), 2022 – 2027
Table-17: Global – Glucose Meter Type 2 Market Share (Percent), 2017 – 2021
Table-18: Global – Forecast for Glucose Meter Type 2 Market Share (Percent), 2022 – 2027
Table-19: Global – Diabetes Population Type 1 Volume Share (Percent), 2017 – 2021
Table-20: Global – Forecast for Diabetes Population Type 1 Volume Share (Percent), 2022 – 2027
Table-21: Global – Diabetes Population Type 2 Volume Share (Percent), 2017 – 2021
Table-22: Global – Forecast for Diabetes Population Type 2 Volume Share (Percent), 2022 – 2027
Table-23: Global – Blood Glucose Device Type 1 User Volume Share (Percent), 2017 – 2021
Table-24: Global – Forecast for Blood Glucose Device Type 1 User Volume Share (Percent), 2022 – 2027
Table-25: Global – Blood Glucose Device Type 2 User Volume Share (Percent), 2017 – 2021
Table-26: Global – Forecast for Blood Glucose Device Type 2 User Volume Share (Percent), 2022 – 2027
Reach out to us
Call us on
USA: +1-678-302-0700
INDIA: +91-120-421-9822
Drop us an email at
info@renub.com